サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1321966

更年期障害の世界市場 - 市場規模、シェア、成長分析：用途別（検査、診断）、エンドユーザー別（病院、診断センター） - 業界予測（2023年～2030年）

Global Menopause Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres) - Industry Forecast 2023-2030
出版日: | 発行: SkyQuest | ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
更年期障害の世界市場 - 市場規模、シェア、成長分析：用途別（検査、診断）、エンドユーザー別（病院、診断センター） - 業界予測（2023年～2030年）
出版日: 2023年07月22日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の更年期障害の市場規模は、2021年に160億1,000万米ドル、2022年に169億米ドルとなりました。同市場は、予測期間中（2023年～2030年）に5.33%のCAGRで拡大し、2030年には244億米ドルに拡大すると予測されています。

更年期は、女性の生殖年齢の終わりを意味する自然な生物学的段階です。一般的に45歳から55歳の間に起こり、月経の停止が特徴です。更年期を迎えた女性は、ほてり、寝汗、気分の落ち込み、膣の乾燥など、さまざまな症状に見舞われます。

更年期障害とそれに伴う症状の蔓延の結果、女性のこれらの症状への対処を支援することを目的とした製品の市場が拡大しています。この市場には、栄養補助食品、ハーブ療法、ビタミン、ミネラル、その他の栄養補助食品のほか、市販薬や処方薬も含まれます。これらの製品は、更年期症状を経験している女性に緩和とサポートを提供するように設計されています。

更年期市場は、高齢化、認知度の向上、ライフスタイルの影響、技術の進歩など様々な要因によって牽引されています。さらに、更年期障害に対する考え方の変化、ヘルスケアへのアクセスと手頃な価格の改善が市場成長に寄与しています。

世界人口の高齢化に伴い、更年期を迎える女性が増加し、更年期関連製品・サービスの市場拡大につながっています。多くの地域で平均寿命が延び、出生率が低下していることから、この人口動向は今後も続くと予想されます。例えば米国では、毎年推定200万人の女性が更年期を経験し、これは毎日約6,000人の女性に相当します。国連の統計によると、2020年の50歳以上の女性の数は9億8,500万人で、2050年には16億5,000万人に達すると予測されています。

更年期障害とその症状に対する社会的認知の高まりが、更年期障害関連商品の市場に大きく貢献しています。女性は更年期に伴う変化や健康リスクについて知識を深めつつあり、更年期症状の管理に役立つ商品やサービスに対する需要の高まりにつながっています。ホルモン療法、ハーブサプリメント、ライフスタイルの調整などは、このような意識の高まりにより求められている解決策の一部です。

当レポートは、世界の更年期障害市場について調査し、市場の概要とともに、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

親市場分析

市場規模

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主要な市場の洞察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 動向分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品分析
  • マクロ経済指標
  • トップ投資分析
  • 主な成功要因
  • 競合の程度

市場力学と展望

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 規制状況
  • ポーター分析

世界の更年期障害市場、用途別

  • 市場概要
  • 検査、診断

世界の更年期障害市場、エンドユーザー別

  • 市場概要
  • 病院
  • 診断センター
  • その他

世界の更年期障害市場、地域別

  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

競合情勢

  • 主要企業プロファイル
    • Pfizer Inc.
    • Novo Nordisk A/S
    • Allergan plc
    • TherapeuticsMD Inc.
    • Mylan N.V.
    • Teva Pharmaceutical Industries Ltd.
    • Bayer AG
    • Merck & Co. Inc.
    • Johnson & Johnson
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • Amgen Inc.
    • AbbVie Inc
    • Pfizer Inc.
    • Novartis International AG
    • Procter & Gamble Co.
    • Roche Holding AG
    • Sanofi SA
    • Serenity Pharmaceuticals LLC
    • Mithra Pharmaceuticals SA
目次
Product Code: SQMIG35I2115

Menopause Market size was valued at USD 16.01 billion in 2021 and is poised to grow from USD 16.9 billion in 2022 to USD 24.4 billion by 2030, growing at a CAGR of 5.33% in the forecast period (2023-2030).

Menopause is a natural biological phase that signifies the end of a woman's reproductive years. Typically occurring between the ages of 45 and 55, it is characterized by the cessation of menstrual periods. Women going through menopause may encounter various symptoms, such as hot flashes, night sweats, mood swings, and vaginal dryness.

As a result of the prevalence of menopause and the associated symptoms, there is a growing market for products aimed at helping women manage these effects. This market includes nutritional supplements, herbal remedies, vitamins, minerals, and other dietary supplements, as well as over-the-counter and prescription medications. These products are designed to provide relief and support for women experiencing menopausal symptoms.

Top-down and bottom-up approaches were used to estimate and validate the size of the Menopause Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Menopause Market Segmental Analysis

Global Menopause Market is segmented based on treatment, and region. Based on treatment, the market is segmented into dietary supplements, OTC pharma products. Further, OTC pharma products is segmented into hormonal and non-hormonal. Based on region, the global Menopause Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The menopause market is being driven by various factors, including the aging population, increased awareness, lifestyle influences, and advancements in technology. Additionally, changing attitudes towards menopause and improved healthcare access and affordability are contributing to market growth.

As the global population ages, more women will go through menopause, leading to a larger market for menopause-related products and services. This demographic trend is expected to continue as life expectancies increase and birth rates decline in many regions. For example, in the United States, an estimated 2 million women experience menopause each year, which amounts to approximately 6,000 women daily. According to UN statistics, there were 985 million women aged 50 years or older in 2020, and this number is projected to reach 1.65 billion by 2050.

Growing public awareness of menopause and its symptoms has significantly contributed to the market for menopause products. Women are becoming more informed about the changes and health risks associated with menopause, leading to an increased demand for goods and services that can help manage menopause symptoms. Hormone therapy, herbal supplements, and lifestyle adjustments are some of the sought-after solutions due to this heightened awareness.

Restraints

Despite significant growth potential, the menopause market faces various challenges that may hinder its expansion. Safety concerns, lack of awareness and stigma, regulatory hurdles, and limited research and development are some of the factors contributing to these challenges.

Safety concerns have arisen regarding hormone replacement therapy (HRT), as studies have linked its use to higher risks of breast cancer, heart disease, and stroke in women. This has led to a growing demand for non-hormonal treatments, posing a challenge for businesses specializing in hormone-based therapies to address these safety issues effectively.

Menopause remains a taboo subject in many countries, leading to limited awareness and understanding of its impact on women's health. The lack of awareness and stigma surrounding menopause may reduce demand and make it difficult for businesses to effectively promote menopause goods and services.

The menopause market is subject to stringent regulatory standards, particularly for hormone-based treatments. Companies developing new medications and therapies must undergo rigorous safety and efficacy evaluations before receiving approval for use. Meeting these regulatory requirements can be a challenging process for market players.

Market Trends

Due to growing concerns about the potential risks associated with hormone-based treatments, an increasing number of women are seeking non-hormonal alternatives to manage the symptoms of menopause. This has led to a rising demand for non-hormonal therapies, including herbal medicines, cognitive-behavioral therapy (CBT), and mindfulness-based treatments, as effective options for addressing menopausal symptoms.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Menopause Market by Applications
    • Market Overview
    • Screening and Diagnosis
  • Global Menopause Market by End User
    • Market Overview
    • Hospital
    • Diagnostic Centres
    • Specialty Clinics
    • Others.
  • Global Menopause Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Allergan plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • TherapeuticsMD Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck & Co. Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Procter & Gamble Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sanofi SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Serenity Pharmaceuticals LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mithra Pharmaceuticals SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • In Feb 2022, Nestle Health Science has completed the final acquisition of Vital Proteins, the one of the leading company in collagen in the United States and a lifestyle and wellness platform offering supplements, beverages and food products. Nestle Health Science acquired a majority stake in Vital Proteins in 2020.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • In 2022, TherapeuticsMD, Inc. (NYSE MKT: TXMD), an women's healthcare company, announced positive top-line results from its pivotal phase 3 Replenish Trial of TX-001HR, an investigational bio-identical hormone therapy combination of 17B-estradiol and progesterone in a single, oral softgel, for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause in post-menopausal women with an intact uterus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments